Clinical data | |
---|---|
Trade names | Tigan, Tebamide |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682693 |
Routes of administration | Oral, rectal, intramuscular |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 60-100% |
Elimination half-life | 7 to 9 hours (mean) |
Excretion | urine (30-50%), faeces |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.848 |
Chemical and physical data | |
Formula | C21H28N2O5 |
Molar mass | 388.464 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Trimethobenzamide (trade names Tebamide, Tigan) is an antiemetic used to prevent nausea and vomiting.